Professor of Obsetrics and Gynecology, Montefiore Medical Center
Obstetrics & Gynecology
Dr. Harriet C. Smith, MD
|
|
Give Review
Harriet Smith is an expert in the field of Obstetrics & Gynecology. She graduated from Medical College of Georgia. She over the years received 6 awards: "Top Doctors: New York Metro Area", "America's Top Doctors", "America's Top Doctors for Cancer", "Top Doctors in Gynecologic Oncology", "Presidents Award, Society of Gynecologic Oncologists" and "Fellow (FACOG)". Harriet C. Smith is a published doctor and has 38 publications published. The lastest was: 'Hemoglobin parameters from diffuse reflectance data.' Harriet Smith is registered with Medicare.
Publications
- Hemoglobin parameters from diffuse reflectance data.
- The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma.
- High prevalence of high grade anal intraepithelial neoplasia in HIV-infected women screened for anal cancer.
- Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): a pooled analysis.
- Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma.
- A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer.
- Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer.
- Detection of cervical intraepithelial neoplasias and cancers in cervical tissue by in vivo light scattering.
- GPR30 predicts poor survival for ovarian cancer.
- Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.
- Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy ...
- In vivo light scattering for the detection of cancerous and precancerous lesions of the cervix.
- Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tub...
- Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.
- In vivo light scattering measurements for detection of precancerous conditions of the cervix.
- GPR30: a novel indicator of poor survival for endometrial carcinoma.
- Changing trends in gestational trophoblastic disease.
- Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003).
- Incidence and survival rates for female malignant germ cell tumors.
- Cervical neoplasia complicating pregnancy.
- Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
- Choriocarcinoma and gestational trophoblastic disease.
- Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study.
- Gestational trophoblastic neoplasia in American Indians.
- Trends in gestational choriocarcinoma: a 27-year perspective.
- Gestational trophoblastic disease epidemiology and trends.
- Persistent low levels of human chorionic gonadotropin: A premalignant gestational trophoblastic disease.
- Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and per...
- Ethnic differences at risk for gestational trophoblastic disease in New Mexico: A 25-year population-based study.
- Primary plasmacytoma arising in an endocervical polyp with detection of neoplastic cells on papanicolaou test. A case report and review of the literature.
- Adenocarcinoma in situ of the cervix: sensitivity of detection by cervical smear: will cytologic screening for adenocarcinoma in situ reduce incidence rates for adenoc...
- Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix?
- Trimetrexate in the treatment of recurrent or advanced leiomyosarcoma of the uterus: a phase II study of the Gynecologic Oncology Group.
- G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth.
- TLK-286.
- Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followe...
- Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.
Schools
Howard University
Doctors Specialties
- Diagnostic Radiology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Top Doctors: New York Metro Area
- America's Top Doctors
- America's Top Doctors for Cancer
- Top Doctors in Gynecologic Oncology
- Presidents Award, Society of Gynecologic Oncologists
- Fellow (FACOG)
Education
-
University of Texas MD Anderson Cancer Center -
Emory University -
Medical College of Georgia -
Medical College of Georgia School of Medicine
Hospital
-
Montefiore Medical Center -
Jacobi Medical Center -
Bronx-Lebanon Hospital Center Health Care System
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1033282348 |
| Last Name Of The Provider | SMITH |
| First Name Of The Provider | HARRIET |
| View All |
Similar Doctors
|
|
Dr. Sonya D. Edwards, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kirby Knox, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dawn C. Nwamuo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nisha Bubna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara L. Schmitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Colleen M. Kavanagh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaskiran K. Grewal, MD |
|
|
Dr. Robert I. Rubeshaw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hani S. Sharkey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Shlomo Leibowich, MB CHB
This Doctor is OpenDoctor Recommended.
|
|
|
Betty J. Calvin, CRT |
|
|
Dr. Agnieszka Vay, MD
This Doctor is OpenDoctor Recommended.
|